MedPath

Use of NIRS in Preterm Population Born at Altitude

Not Applicable
Completed
Conditions
Prematurity; Extreme
Interventions
Device: Near-infrared spectroscopy (NIRS) utilization
Registration Number
NCT04639583
Lead Sponsor
University of New Mexico
Brief Summary

Near-infrared spectroscopy (NIRS), is a technology that can provide continuous, non-invasive monitoring of oxygenation in tissue. The objective of this study is to obtain the cerebral regional oxygen saturation (cRSO2) in a preterm population that is born at altitude to determine if the range of "normal" values is different than those obtained at sea level.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Infant must be <32 weeks' gestational age at time of delivery.
  • Consenting mother/guardian of the infant must speak English. Other languages are not being included due to the need of a translator being brought into the unit, which adds risk to the vulnerable population. Additionally, as the time to consent is a narrow window, adding the complexity of getting a translator may delay the ability to get consent and thus make it more difficult to enroll patients.
  • Infants that require blood transfusions during the monitoring time may be included.
Exclusion Criteria
  • Any known cardiac anomaly or other anomaly which may impair perfusion and blood flow.
  • Infant born after placental abruption or concern for extreme blood loss immediately after birth.
  • Unable to consent the mother/guardian due to maternal health issues after delivering (eg requiring intubation or sedation after the delivery).
  • Mothers/guardians that are prisoners, as the study team would like to have continuing communication with the mother during the study period as needed.
  • Mothers/guardians that are <18 years of age will not be approached for consent.
  • Any mother/guardian that is not able to consent due to having a legal representative will not be approached for consent in this study.
  • Any infant that is planned to be placed for adoption
  • Infant is greater than 24 hours of age at time of consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Observational ArmNear-infrared spectroscopy (NIRS) utilizationAny infant consented to participate in the study will have the NIRS applied for the first 96 hours of life. It will be the goal to apply the NIRS sensors in the first 12 hours of life. All infants will have the same treatment if in the study, but clinicians will not be able to see the data obtained so that there is no clinical interpretation during this time.
Primary Outcome Measures
NameTimeMethod
Cerebral Regional Oxygen Saturation (cRSO2)first 96 hours of life

Measure cRSO2 for the first 96 hours of life in infants born preterm.

Secondary Outcome Measures
NameTimeMethod
Incidence of Major Complications of PrematurityFrom birth until the end of the birth hospitalization, which would be discharge home or death, whichever occurs first. Estimated time is up to 6 months of age.

Additional items recorded to determine if there is any correlation with the cRSO2 values, including death, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, duration of supplemental oxygen required, time to taking full volume feeds via nippling, and hospital length of stay.

Trial Locations

Locations (1)

University of New Mexico

🇺🇸

Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath